Cargando…

In vivo polarisation sensitive optical coherence tomography for fibrosis assessment in interstitial lung disease: a prospective, exploratory, observational study

INTRODUCTION: Endobronchial polarisation sensitive optical coherence tomography (EB-PS-OCT) is a bronchoscopic imaging technique exceeding resolution of high-resolution CT (HRCT) by 50-fold. It detects collagen birefringence, enabling identification and quantification of fibrosis. STUDY AIM: To asse...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaselli, Margherita, Kalverda-Mooij, Kirsten, Thunnissen, Erik, Tanck, Michael W T, Mets, Onno M, van den Berk, Inge A H, Annema, Jouke T, Bonta, Peter I, de Boer, Johannes F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414088/
https://www.ncbi.nlm.nih.gov/pubmed/37553184
http://dx.doi.org/10.1136/bmjresp-2023-001628
_version_ 1785087270185861120
author Vaselli, Margherita
Kalverda-Mooij, Kirsten
Thunnissen, Erik
Tanck, Michael W T
Mets, Onno M
van den Berk, Inge A H
Annema, Jouke T
Bonta, Peter I
de Boer, Johannes F
author_facet Vaselli, Margherita
Kalverda-Mooij, Kirsten
Thunnissen, Erik
Tanck, Michael W T
Mets, Onno M
van den Berk, Inge A H
Annema, Jouke T
Bonta, Peter I
de Boer, Johannes F
author_sort Vaselli, Margherita
collection PubMed
description INTRODUCTION: Endobronchial polarisation sensitive optical coherence tomography (EB-PS-OCT) is a bronchoscopic imaging technique exceeding resolution of high-resolution CT (HRCT) by 50-fold. It detects collagen birefringence, enabling identification and quantification of fibrosis. STUDY AIM: To assess pulmonary fibrosis in interstitial lung diseases (ILD) patients with in vivo EB-PS-OCT using histology as reference standard. PRIMARY OBJECTIVE: Visualisation and quantification of pulmonary fibrosis by EB-PS-OCT. SECONDARY OBJECTIVES: Comparison of EB-PS-OCT and HRCT detected fibrosis with histology, identification of ILD histological features in EB-PS-OCT images and comparison of ex vivo PS-OCT results with histology. METHODS: Observational prospective exploratory study. Patients with ILD scheduled for transbronchial cryobiopsy or surgical lung biopsy underwent in vivo EB-PS-OCT imaging prior to tissue acquisition. Asthma patients were included as non-fibrotic controls. Per imaged lung segment, fibrosis was automatically quantified assessing the birefringent area in EB-PS-OCT images. Fibrotic extent in corresponding HRCT areas and biopsies were compared with EB-PS-OCT detected fibrosis. Microscopic ILD features were identified on EB-PS-OCT images and matched with biopsies from the same segment. RESULTS: 19 patients were included (16 ILD; 3 asthma). In 49 in vivo imaged airway segments the parenchymal birefringent area was successfully quantified and ranged from 2.54% (no to minimal fibrosis) to 21.01% (extensive fibrosis). Increased EB-PS-OCT detected birefringent area corresponded to increased histologically confirmed fibrosis, with better predictive value than HRCT. Microscopic ILD features were identified on both in vivo and ex vivo PS-OCT images. CONCLUSIONS: EB-PS-OCT enables pulmonary fibrosis quantification, thereby has potential to serve as an add-on bronchoscopic imaging technique to diagnose and detect (early) fibrosis in ILD.
format Online
Article
Text
id pubmed-10414088
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-104140882023-08-11 In vivo polarisation sensitive optical coherence tomography for fibrosis assessment in interstitial lung disease: a prospective, exploratory, observational study Vaselli, Margherita Kalverda-Mooij, Kirsten Thunnissen, Erik Tanck, Michael W T Mets, Onno M van den Berk, Inge A H Annema, Jouke T Bonta, Peter I de Boer, Johannes F BMJ Open Respir Res Interstitial Lung Disease INTRODUCTION: Endobronchial polarisation sensitive optical coherence tomography (EB-PS-OCT) is a bronchoscopic imaging technique exceeding resolution of high-resolution CT (HRCT) by 50-fold. It detects collagen birefringence, enabling identification and quantification of fibrosis. STUDY AIM: To assess pulmonary fibrosis in interstitial lung diseases (ILD) patients with in vivo EB-PS-OCT using histology as reference standard. PRIMARY OBJECTIVE: Visualisation and quantification of pulmonary fibrosis by EB-PS-OCT. SECONDARY OBJECTIVES: Comparison of EB-PS-OCT and HRCT detected fibrosis with histology, identification of ILD histological features in EB-PS-OCT images and comparison of ex vivo PS-OCT results with histology. METHODS: Observational prospective exploratory study. Patients with ILD scheduled for transbronchial cryobiopsy or surgical lung biopsy underwent in vivo EB-PS-OCT imaging prior to tissue acquisition. Asthma patients were included as non-fibrotic controls. Per imaged lung segment, fibrosis was automatically quantified assessing the birefringent area in EB-PS-OCT images. Fibrotic extent in corresponding HRCT areas and biopsies were compared with EB-PS-OCT detected fibrosis. Microscopic ILD features were identified on EB-PS-OCT images and matched with biopsies from the same segment. RESULTS: 19 patients were included (16 ILD; 3 asthma). In 49 in vivo imaged airway segments the parenchymal birefringent area was successfully quantified and ranged from 2.54% (no to minimal fibrosis) to 21.01% (extensive fibrosis). Increased EB-PS-OCT detected birefringent area corresponded to increased histologically confirmed fibrosis, with better predictive value than HRCT. Microscopic ILD features were identified on both in vivo and ex vivo PS-OCT images. CONCLUSIONS: EB-PS-OCT enables pulmonary fibrosis quantification, thereby has potential to serve as an add-on bronchoscopic imaging technique to diagnose and detect (early) fibrosis in ILD. BMJ Publishing Group 2023-08-08 /pmc/articles/PMC10414088/ /pubmed/37553184 http://dx.doi.org/10.1136/bmjresp-2023-001628 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Interstitial Lung Disease
Vaselli, Margherita
Kalverda-Mooij, Kirsten
Thunnissen, Erik
Tanck, Michael W T
Mets, Onno M
van den Berk, Inge A H
Annema, Jouke T
Bonta, Peter I
de Boer, Johannes F
In vivo polarisation sensitive optical coherence tomography for fibrosis assessment in interstitial lung disease: a prospective, exploratory, observational study
title In vivo polarisation sensitive optical coherence tomography for fibrosis assessment in interstitial lung disease: a prospective, exploratory, observational study
title_full In vivo polarisation sensitive optical coherence tomography for fibrosis assessment in interstitial lung disease: a prospective, exploratory, observational study
title_fullStr In vivo polarisation sensitive optical coherence tomography for fibrosis assessment in interstitial lung disease: a prospective, exploratory, observational study
title_full_unstemmed In vivo polarisation sensitive optical coherence tomography for fibrosis assessment in interstitial lung disease: a prospective, exploratory, observational study
title_short In vivo polarisation sensitive optical coherence tomography for fibrosis assessment in interstitial lung disease: a prospective, exploratory, observational study
title_sort in vivo polarisation sensitive optical coherence tomography for fibrosis assessment in interstitial lung disease: a prospective, exploratory, observational study
topic Interstitial Lung Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414088/
https://www.ncbi.nlm.nih.gov/pubmed/37553184
http://dx.doi.org/10.1136/bmjresp-2023-001628
work_keys_str_mv AT vasellimargherita invivopolarisationsensitiveopticalcoherencetomographyforfibrosisassessmentininterstitiallungdiseaseaprospectiveexploratoryobservationalstudy
AT kalverdamooijkirsten invivopolarisationsensitiveopticalcoherencetomographyforfibrosisassessmentininterstitiallungdiseaseaprospectiveexploratoryobservationalstudy
AT thunnissenerik invivopolarisationsensitiveopticalcoherencetomographyforfibrosisassessmentininterstitiallungdiseaseaprospectiveexploratoryobservationalstudy
AT tanckmichaelwt invivopolarisationsensitiveopticalcoherencetomographyforfibrosisassessmentininterstitiallungdiseaseaprospectiveexploratoryobservationalstudy
AT metsonnom invivopolarisationsensitiveopticalcoherencetomographyforfibrosisassessmentininterstitiallungdiseaseaprospectiveexploratoryobservationalstudy
AT vandenberkingeah invivopolarisationsensitiveopticalcoherencetomographyforfibrosisassessmentininterstitiallungdiseaseaprospectiveexploratoryobservationalstudy
AT annemajouket invivopolarisationsensitiveopticalcoherencetomographyforfibrosisassessmentininterstitiallungdiseaseaprospectiveexploratoryobservationalstudy
AT bontapeteri invivopolarisationsensitiveopticalcoherencetomographyforfibrosisassessmentininterstitiallungdiseaseaprospectiveexploratoryobservationalstudy
AT deboerjohannesf invivopolarisationsensitiveopticalcoherencetomographyforfibrosisassessmentininterstitiallungdiseaseaprospectiveexploratoryobservationalstudy